uk

A UK charity that funds research into DIPG, a brainstem tumour of children, including UK CAR-T cell trials, and gives families information about the disease.

A surgical centre for NHS Scotland North, serving Grampian and the islands; a Precision-Panc and ginisortamab trial site.

The East of England's HPB specialist centre, with liver transplantation; a BILCAP site and a site of the UK biliary microbiome study.

In England and Wales, an adult can write down in advance which treatments they refuse if they later cannot decide. To refuse treatment that keeps you alive, it must be in writing, signed, witnessed and say it applies even if your life is at risk.

A charity that encourages people of Black and mixed heritage to join the UK stem cell, blood and organ donor registers, so that more patients find a match.

In England the offer has four named parts: an assessment of what you need and a plan written with you, information and support about living well, a summary of your treatment sent to you and your GP, and a review with your GP. Follow-up is increasingly not a routine clinic appointment but a pathway you manage yourself, with tests at set intervals and a route back in.

The largest randomised trial ever run inside a screening programme: nearly four million women cluster-randomised to an extra mammogram below 50 or above 70, and the reason the programme's age range has not moved.

The Newcastle oncologist who led the NHS England pilot that put a blood test for lung cancer mutations into the diagnostic pathway, and who co-leads the CONCORDE radiotherapy platform.

The UK's only charity dedicated to cholangiocarcinoma and the other biliary tract cancers: patient information, a list of UK centres with expertise, research grants, an annual conference and a nurse study day.

The Glasgow surgeon-scientist who mapped the genomic subtypes of pancreatic cancer and built Precision-Panc, the UK programme that profiled tumours to route patients into the PRIMUS trials.

Medical oncologist who co-chairs the breast disease group at The Christie, the Manchester cancer centre that is a site of the PHOENIX, PARTNER and ASCENT-05 trials for triple-negative disease.

The UK stem cell register, founded in 1974, and the charity behind the clinical nurse specialists who look after transplant patients in NHS centres.

This Scottish member's bill would have let eligible terminally ill adults in Scotland ask for help from health professionals to end their own life. It fell at the final stage on 17 March 2026, so it is not law.

Northern Ireland's single HPB cancer service, within the Belfast Trust; systemic treatment at the Northern Ireland Cancer Centre.

The British trial that asked, without enthusiasm or spin, what chemotherapy is actually worth in lung cancer, and found it worth nine weeks in advanced disease and nothing at all after surgery or radiotherapy.

Liverpool molecular scientist behind the EUROPAC registry's laboratory work and the biomarker analyses of the ESPAC trial samples.

The UK's blood cancer research charity and support line, covering lymphoma alongside leukaemia and myeloma.

A UK charity for people affected by primary bone cancer: it funds research, provides information and support, and speaks for patients.

The UK's bowel cancer charity: information and an email service answered by colorectal nurses, the Never Too Young campaign for younger patients, and the policy work that pushes the NHS on screening, Lynch syndrome testing and emergency diagnosis.

The UK medical research charity for bowel disease: small proof-of-concept grants and PhDs in bowel cancer and inflammatory bowel disease, with patients on its review panels.

A UK charity that funds a network of brain tumour research centres and campaigns for more national spending on brain tumour research.

A charity offering free specialist support to people with a brain tumour and their families: a support line, counselling and support groups.

The UK's breast cancer research and support charity: a free nurse helpline, the Someone Like Me peer service, Moving Forward courses, an online forum and patient information on triple-negative disease, alongside funding of the Toby Robins Research Centre at the ICR.

A UK charity dedicated to preventing breast cancer through research, education and campaigns, including on chemicals in everyday products.

The professional body that writes the UK's skin cancer service standards and, because these cancers have almost no charity of their own, also writes most of the patient information a person with a basal cell carcinoma will be handed.

Britain's own survivor cohort, built on national registration rather than on hospital volunteers, which is why it can follow people for half a century and count deaths that nobody reported. Its central finding is that what kills survivors changes with time: recurrence early, second cancers and heart disease late.

The UK professional society for doctors, nurses and scientists who treat and research gynaecological cancers.

The UK's multidisciplinary professional group for doctors, nurses and others who treat lung cancer, mesothelioma and other chest cancers.

An NHS England fund that pays for promising cancer drugs while more evidence is collected, born in 2010 as a political fix for drugs NICE had refused and rebuilt in 2016 into a time-limited managed access scheme with a fixed budget.

The UCL urologist who has spent her career on the two questions that decide whether a man with prostate cancer is harmed by being diagnosed: who needs a biopsy, and who needs treating at all.

The HPB specialist centre for Hull and East Yorkshire, one of the 23 English surgical hubs in the National Pancreatic Cancer Audit and a Precision-Panc site.

The Jewish community's national cancer support charity, giving free counselling, therapies and advice to patients, family and friends at centres around the UK.

A British radiotherapy schedule, invented at Mount Vernon, that squeezed a six-week course into twelve days and cut the risk of death by about a quarter.

The UK charity for anyone affected by retinoblastoma, a rare eye cancer of young children, offering lifelong support, awareness of the signs and research funding.

A London charity, founded in 1987 by the family of a boy who died of leukaemia, that funds childhood cancer research and supports families.

A North East charity that supports children with cancer treated at the Great North Children's Hospital and funds childhood cancer research in Newcastle.

A UK charity, registered in 2017, that funds chordoma research and gives people with chordoma information and a peer support group.

Liverpool pancreatic surgeon who leads EUROPAC, the UK registry and surveillance programme for families with inherited pancreatic cancer risk and hereditary pancreatitis.

Led COMFORT-II, which established ruxolitinib as the first drug for myelofibrosis, and most UK MPN trials since.

The charity of The Clatterbridge Cancer Centre, which pays for research, equipment and better treatment spaces for patients in Cheshire and Merseyside.

A non-profit working in the UK, Spain and France that funds translational cancer research, including childhood and blood cancers.

A blood cancer charity that pays for specialist research nurses at UK centres so that adults and children can join clinical trials of new treatments.

Liverpool medical oncologist, second author of ESPAC-4 and co-lead of ESPAC5, who directs the Liverpool Experimental Cancer Medicine Centre and leads the national GIRFT review of pancreatic cancer services.

The Nottingham chest physician who chairs the UK clinical expert group for lung cancer and advises the National Screening Committee: the person whose job it is to turn the screening evidence into an NHS service.

The Leeds clinical oncologist who led CR07, the trial that made short-course radiotherapy before surgery the standard for rectal cancer, and who now works on preserving the rectum instead of removing it.

Led CONFIRM and MARS 2, which showed nivolumab helps relapsed mesothelioma and that radical surgery does not.

The HPB specialist centre for the South West Peninsula (Devon, Cornwall and the Isles of Scilly); a BILCAP site.

The Birmingham surgeon who chairs FOxTROT and runs the surgical trials programme that tests how bowel cancer operations are done, not just which drugs come with them.

First author of POSH, the UK prospective cohort of young-onset breast cancer that showed germline BRCA carriers did no worse than non-carriers, and the ones with triple-negative disease did better in the first two years.

A charity that takes young people aged 8 to 24 who have had cancer on free sailing and outdoor adventures to rebuild confidence after treatment.

The UK's registry and screening programme for families with inherited pancreatic cancer risk, run from Liverpool since 2000; its 2026 outcomes paper shows risk-stratified surveillance finds four times more actionable lesions.

A UK bladder cancer charity founded and run by survivors and their families, offering a forum, support groups and information, and backing research.

A charity started in 2019 that funds research aimed at curing follicular lymphoma and provides information for people living with it.

The UK trial that showed giving some chemotherapy before the operation for colon cancer shrinks the tumour, leaves cleaner margins and cuts the chance of the cancer coming back.

The Birmingham oncologist who ran the National Lung Matrix Trial, the largest umbrella trial in lung cancer, and published the honest answer: most drug-biomarker pairs did not work.

The HPB surgical centre for the West of Scotland Cancer Network; chemotherapy and immunotherapy are given at the Beatson.

The Gold Standards Framework is a UK charity that trains GP practices, care homes and other services to care well for people in the last years of life, and accredits those that do. Its site lists accredited care homes and providers.

Led Myeloma XI, the 4,000-patient UK trial that proved lenalidomide maintenance extends survival after transplant.

Liver surgeon at Aintree who co-wrote the BSG cholangiocarcinoma guideline and is a co-author of the UK-wide CAPBIL studies of gallbladder cancer surgery; a past president of the British Association of Surgical Oncology.

Surgeon who led De-ESCALaTE and PET-NECK, two trials that changed how HPV-positive throat cancer is treated and followed up.